Robert Babela

Robert Babela is a Professor of Public Health and Vice-Chancellor responsible for research and development at the Slovak Medical University in Bratislava, Slovakia. He specializes in the field of health technology assessment and has been working in this area for over a decade. He holds several degrees, including an MSc in International Health Technology Assessment, Pricing and Reimbursement from the University of Sheffield in Sheffield, UK. He has authored and co-authored more than 180 publications both domestically and internationally. Additionally, he has gained practical skills through his more than twenty years of experience in various roles in the healthcare sector, where he currently continues to work.

In his recent role as State Secretary at the Ministry of Health, he led the team responsible for a major drug policy change during the last decade, which was approved by the Slovak parliament and has been in effect since August 1, 2022. Currently, he prioritizes scientific projects related to the burden of chronical diseases in Slovakia and evaluates the cost-effectiveness of selected oncology screenings for the National Cancer Institute.